July 31, 2023 02:46 PM EDTUpdated 03:24 PM
Pharma

Vi­a­tris launch­es gener­ic for As­traZeneca's asth­ma and COPD drug Sym­bi­cort

Katherine Lewin

News Reporter

As­traZeneca’s block­buster asth­ma and COPD drug Sym­bi­cort, which brought in $2.5 bil­lion for the phar­ma gi­ant in 2022, now has a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Key GOP sen­a­tor is ‘strug­gling’ with Kennedy nom­i­na­tion over vac­cine an­swers

Roche aims for de­risked deals and ruth­less port­fo­lio cuts in 2025

Take­da scraps pro­grams as it rais­es full-year guid­ance 

Sanofi is in the mar­ket for M&A, thanks to ‘strong’ bal­ance sheet

Black­stone se­cures $1.6B so far for new life sci­ences fund tar­get­ed at $5B+

sponsored

Why the pre­mier re­cruit­ment agency in the world is giv­ing up re­cruit­ing, and spon­sors should, too

A service from the Financial Times